Albany, NY -- (SBWIRE) -- 11/27/2015 -- According to a new market report published by Transparency Market Research "Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023", the global mice model market was valued at USD 1.01 billion in 2013 and is anticipated to expand at a CAGR of 6.4% from 2015 to 2023 to reach USD 1.75 billion by 2023.

Browse the full Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/mice-model-market.html

Mice have been one of the most important research tools for basic and applied research in biomedical sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the prospect of exploring precise gene-specific functions and various molecular events in a living organism. Combining mice models with advanced imaging technologies provide unique opportunities to understand the etiology and pathophysiology of human diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and conditions. For example, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia, or APL, which was largely terminal.

An expanding collection of gene technology, together with sequencing of the mice genome and biological conservation, place the mouse at the leading position as a model to decode mechanisms underlying human disease progression. More than any other genetically tractable research animal, mice offer a close view of human biology in terms of resemblance with the pathophysiology, cellular structure, and organization. With 99% of their genes shared with humans, new possibilities were opened in genetic testing, drug discovery, and other basic research. Furthermore, the conservation of genetic association within the mice and human genomes with respect to the encoded genes and their alignment along chromosomes has been a great advantage in identification of potentially conforming homologous mutations and disease genes.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

The global mice model market has been segmented on the basis of model type, specialty, services, and geography. Based on model type, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Moreover, the hybrid/congenic segment is expected to expand at the highest CAGR during the forecast period from 2015 to 2023 due to increasing applications in immunology, oncology, and cardiovascular studies. Based on specialty, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Metabolic & regulatory diseases was the largest specialty segment of the market in terms of revenue in 2014. The diabetes mice models specialty segment is likely to expand at the highest growth rate due to rising prevalence of the disease across the globe, particularly in developed countries. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services, and other services such as surgical and line rescue. The major factor influencing the growth of the services market is the growing importance of customized models in applied research as well as in the development and production of vital biomolecules.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/mice-model-market.htm

Key players operating in the global mice model market include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, and TransGenic, Inc.

The global mice model market has been segmented as follows:

Global Mice Model Market, by Type
Transgenic Mice Model
Hybrid/Congenic Mice Model
Knockout Mice Model
Carcinogen/induced and Spontaneous Mice Model
Outbred Mice Model
Inbred Mice Model
Transplantation Mice Model
Conditioned/Surgically Modified Mice Model
Global Mice Model Market, by Specialty
Immunology
Central Nervous System
Oncology
Cardiovascular
Diabetes
Metabolism & Regulation
Global Mice Model Market, by Services
Breeding and Rederivation Services
Cryopreservation and Cryorecovery Services
Quarantine Services
Genetic Testing Services
Model In-licensing Services
In vivo and In vitro Pharmacology Services
Other Services (Surgical and Line Rescue)
Global Mice Model Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific (APAC)
Japan
China
Rest of APAC
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & North Africa (MENA)
Saudi Arabia
UAE
Israel
Rest of MENA
Rest of the World (RoW)

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/